News
LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development. The pharmaceutical company’s Boston-based R&D ...
In his new role, Leo Landis will showcase the Society's attractions across the state and connect people both within and ...
The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have approved a change to the terms of the marketing authorisation for LEO Pharma’s Adtralza ...
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...
Strides Pharma Science Ltd, Aarti Pharma Ltd, Marksans Pharma Ltd, Laurus Labs and IPCA Labs led losers on the BSE Healthcare index, as the party got over in the pharma pack early after the US ...
“Our first reaction is one of relief. That said, we remain very vigilant and concerned about the future,” said David Gering from Pharma.be. He added that the American market represents a signi ...
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and personalized experiences. The Fast Company Executive Board is a private ...
Currently, many new drugs come on stream in some EU states much quicker than others. [ Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reformsOpens ...
My wife and I would both be dead, but for what many derisively call “Big Pharma.” My wife has a rare, genetic form of stage four lung cancer for which there is no cure. Her lungs are filled ...
Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...
IT WAS ALSO PART HAPPENSTANCE. YOU SEE HER BELOVED CORGI, LEO WAS A BIT OF A RAMBUNCTIOUS FELLOW WHO WOULD NIBBLE AND CHEW ON ALMOST ANYTHING AROUND THE HOUSE, EXCEPT WHEN IT CAME TO MATERIALS ...
NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results